✦ LIBER ✦

P.04.25 ROLE OF CYP2C1917 AND CYP2C192 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS

✍ Scribed by Franceschi, M.; Seripa, D.; Giulia, P.; Bazzano, S.; Gravina, C.; Urbano, M.; Baldassarre, G.; Di Mario, F.; Pilotto, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of CYP2C9 and CYP2C19 polymorphisms

✍ B. Ercan; L. Ayaz; D. Çiçek; L. Tamer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Assessment of CYP2C19 genetic polymorphi

✍ K.-A. Kim; W.-K. Song; K.-R. Kim; J.-Y. Park 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Effect of CYP2C19 *2 and *17 mutations o

✍ Nicole G. Hunfeld; Ron A. Mathot; Daan J. Touw; Ron H. Van Schaik; Paul G. Mulde 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 703 KB

CYP2C19 Genotype and Pharmacokinetics of

✍ Toshiyuki Sakai; Nobuo Aoyama; Tomoko Kita; Toshiyuki Sakaeda; Kohshi Nishiguchi 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 163 KB

Genotypes for the cytochrome P450 enzyme

✍ L. Bathum; K. Andersen-Ranberg; J. Boldsen; K. Brøsen; B. Jeune 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 138 KB

Impact of the CYP2C19*17 Polymorphism on

✍ Mazer-Amirshahi, Maryann; van den Anker, John 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 102 KB

P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS